Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CPX chromosomal region candidate gene 1 protein (CPXCR1) is a protein encoded by the CPXCR1 gene, located on the X chromosome in a region associated with the X-linked cleft palate (CPX) disorder[2][3][5]. The protein contains a sequence motif similar to those found in zinc-finger proteins, suggesting a possible role in DNA or RNA binding, but its exact biological function remains uncharacterized[2][9]. Mutation analysis has not demonstrated a causative link between CPXCR1 and cleft palate in human patients, though several alternatively spliced variants encoding the same protein have been detected[2][5]. There is no evidence for CPXCR1 being an established therapeutic target, and there are no drugs reported to interact with it in current biomedical databases[2][7]. The protein has also been referenced under the names CT77 and as a cancer/testis antigen 77, but direct functional evidence for these roles is limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CPX chromosomal region candidate gene 1 protein (CPXCR1).